Alerts will be sent to your verified email
Verify Email
OXYGENTAPH
|
Oxygenta Pharma
|
Gennex Lab
|
Fredun Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.1 % | 7.82 % | 8.53 % |
|
5yr average Equity Multiplier
|
-1.22 | 1.53 | 3.02 |
|
5yr Average Asset Turnover Ratio
|
1.1 | 0.75 | 1.01 |
|
5yr Avg Net Profit Margin
|
-16.74 % | 7.88 % | 2.89 % |
|
Price to Book
|
0.0 | 1.66 | 2.51 |
|
P/E
|
0.0 | 16.11 | 17.46 |
|
5yr Avg Cash Conversion Cycle
|
-56.32 Days | 43.23 Days | 137.13 Days |
|
Inventory Days
|
94.46 Days | 49.12 Days | 140.46 Days |
|
Days Receivable
|
80.66 Days | 50.53 Days | 52.11 Days |
|
Days Payable
|
174.19 Days | 75.36 Days | 131.93 Days |
|
5yr Average Interest Coverage Ratio
|
-3.11 | 6.21 | 2.31 |
|
5yr Avg ROCE
|
-80.86 % | 11.17 % | 16.75 % |
|
5yr Avg Operating Profit Margin
|
-18.99 % | 10.47 % | 8.32 % |
|
5 yr average Debt to Equity
|
-1.55 | 0.18 | 0.86 |
|
5yr CAGR Net Profit
|
-9.68 % | 43.63 % | 52.4 % |
|
5yr Average Return on Assets
|
-10.42 % | 5.16 % | 3.05 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.12 % | 18.42 % | 48.93 % |
|
Share Pledged by Promoters
|
0.0 | 23.87 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
38.79 % | -3.63 % | -2.34 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.04 % | 0.0 | 0.0 |
|
Oxygenta Pharma
|
Gennex Lab
|
Fredun Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|